Bellevue Group Ag 10x Genomics, Inc. Transaction History

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

A detailed history of Bellevue Group Ag transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 281,881 shares of TXG stock, worth $4.56 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
281,881
Previous 308,311 8.57%
Holding current value
$4.56 Million
Previous $6 Million 6.14%
% of portfolio
0.11%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.71 - $23.49 $415,215 - $620,840
-26,430 Reduced 8.57%
281,881 $6.36 Million
Q1 2024

May 15, 2024
BUY
$36.08 - $54.3 $546,179 - $821,993
15,138 Added 5.16%
308,311 $11.6 Million
Q4 2023

Feb 14, 2024
SELL
$34.32 - $57.55 $43,208 - $72,455
-1,259 Reduced 0.43%
293,173 $16.4 Million
Q3 2023

Nov 14, 2023
SELL
$40.86 - $62.98 $1.24 Million - $1.91 Million
-30,314 Reduced 9.33%
294,432 $12.1 Million
Q4 2022

Feb 14, 2023
BUY
$24.4 - $41.3 $1.72 Million - $2.92 Million
70,612 Added 27.79%
324,746 $11.8 Million
Q3 2022

Nov 14, 2022
SELL
$28.48 - $52.59 $149,149 - $275,413
-5,237 Reduced 2.02%
254,134 $7.24 Million
Q2 2022

Aug 11, 2022
BUY
$36.95 - $82.41 $240,618 - $536,653
6,512 Added 2.58%
259,371 $11.7 Million
Q1 2022

May 13, 2022
BUY
$55.7 - $145.79 $1.12 Million - $2.94 Million
20,187 Added 8.68%
252,859 $19.2 Million
Q2 2021

Aug 12, 2021
BUY
$134.22 - $202.37 $487,621 - $735,210
3,633 Added 1.59%
232,672 $45.6 Million
Q1 2021

May 12, 2021
BUY
$140.25 - $196.86 $8.96 Million - $12.6 Million
63,916 Added 38.71%
229,039 $41.5 Million
Q4 2020

Feb 16, 2021
BUY
$126.47 - $163.7 $1.41 Million - $1.82 Million
11,134 Added 7.23%
165,123 $23.4 Million
Q3 2020

Nov 16, 2020
BUY
$87.44 - $125.0 $2.7 Million - $3.86 Million
30,912 Added 25.12%
153,989 $19.2 Million
Q2 2020

Aug 13, 2020
BUY
$58.39 - $89.31 $1.71 Million - $2.61 Million
29,230 Added 31.15%
123,077 $11 Million
Q1 2020

May 14, 2020
SELL
$51.57 - $106.62 $1.82 Million - $3.76 Million
-35,280 Reduced 27.32%
93,847 $5.85 Million
Q4 2019

Feb 14, 2020
BUY
$46.07 - $79.54 $1.34 Million - $2.32 Million
29,127 Added 29.13%
129,127 $9.85 Million
Q3 2019

Nov 14, 2019
BUY
$49.99 - $62.0 $5 Million - $6.2 Million
100,000 New
100,000 $5.04 Million

Others Institutions Holding TXG

# of Institutions
293
Shares Held
96.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email